A novel indication of platonin, a therapeutic immunomodulating medicine, on neuroprotection against ischemic stroke in mice

Joen Rong Sheu, Zhih Cherng Chen, Thanasekaran Jayakumar, Duen Suey Chou, Ting Lin Yen, Hsing Ni Lee, Szu Han Pan, Chih Hsuan Hsia, Chih Hao Yang, Cheng Ying Hsieh

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Thrombosis and stroke are major causes of disability and death worldwide. However, the regular antithrombotic drugs may have unsatisfactory results and side effects. Platonin, a cyanine photosensitizing dye, has been used to treat trauma, ulcers and some acute inflammation. Here, we explored the neuroprotective effects of platonin against middle cerebral artery occlusion (MCAO)-induced ischemic stroke in mice. Platonin(200 μg/kg) substantially reduced cerebral infarct volume, brain edema, neuronal cell death and neurological deficit scores, and improved the MCAO-reduced locomotor activity and rotarod performance. Platonin(5-10 μM) potently inhibited platelet aggregation and c-Jun NH2-terminal kinase (JNK) phosphorylation in collagen-activated platelets. The antiaggregation effect did not affect bleeding time but increased occlusion time in platonin(100 and 200 μg/kg)-treated mice. Platonin(2-10 μM) was potent in diminishing collagen- and Fenton reaction-induced a OH formation. Platonin(5-10 μM) also suppressed the expression of nitric oxide, inducible nitric oxide synthase, cyclooxygenase-2, interleukin-1β, and JNK phosphorylation in lipopolysaccharide-stimulated macrophages. MCAO-induced expression of 3-nitrotyrosine and Iba1 was apparently attenuated in platonin(200 μg/kg)-treated mice. In conclusion, platonin exhibited remarkable neuroprotective properties against MCAO-induced ischemia in a mouse model through its antiaggregation, antiinflammatory and antiradical properties. The observed therapeutic efficacy of platonin may consider being a novel medcine against ischemic stroke.

Original languageEnglish
Article number42277
JournalScientific Reports
Volume7
DOIs
Publication statusPublished - Feb 6 2017

Fingerprint

Stroke
Medicine
Middle Cerebral Artery Infarction
Therapeutics
JNK Mitogen-Activated Protein Kinases
Collagen
Phosphorylation
platonin
Neuroprotection
Bleeding Time
Brain Edema
Neuroprotective Agents
Nitric Oxide Synthase Type II
Cyclooxygenase 2
Locomotion
Interleukin-1
Platelet Aggregation
Ulcer
Lipopolysaccharides
Cause of Death

ASJC Scopus subject areas

  • General

Cite this

A novel indication of platonin, a therapeutic immunomodulating medicine, on neuroprotection against ischemic stroke in mice. / Sheu, Joen Rong; Chen, Zhih Cherng; Jayakumar, Thanasekaran; Chou, Duen Suey; Yen, Ting Lin; Lee, Hsing Ni; Pan, Szu Han; Hsia, Chih Hsuan; Yang, Chih Hao; Hsieh, Cheng Ying.

In: Scientific Reports, Vol. 7, 42277, 06.02.2017.

Research output: Contribution to journalArticle

@article{8c8a4b68e48b4f87aaa0e4388ddacc34,
title = "A novel indication of platonin, a therapeutic immunomodulating medicine, on neuroprotection against ischemic stroke in mice",
abstract = "Thrombosis and stroke are major causes of disability and death worldwide. However, the regular antithrombotic drugs may have unsatisfactory results and side effects. Platonin, a cyanine photosensitizing dye, has been used to treat trauma, ulcers and some acute inflammation. Here, we explored the neuroprotective effects of platonin against middle cerebral artery occlusion (MCAO)-induced ischemic stroke in mice. Platonin(200 μg/kg) substantially reduced cerebral infarct volume, brain edema, neuronal cell death and neurological deficit scores, and improved the MCAO-reduced locomotor activity and rotarod performance. Platonin(5-10 μM) potently inhibited platelet aggregation and c-Jun NH2-terminal kinase (JNK) phosphorylation in collagen-activated platelets. The antiaggregation effect did not affect bleeding time but increased occlusion time in platonin(100 and 200 μg/kg)-treated mice. Platonin(2-10 μM) was potent in diminishing collagen- and Fenton reaction-induced a OH formation. Platonin(5-10 μM) also suppressed the expression of nitric oxide, inducible nitric oxide synthase, cyclooxygenase-2, interleukin-1β, and JNK phosphorylation in lipopolysaccharide-stimulated macrophages. MCAO-induced expression of 3-nitrotyrosine and Iba1 was apparently attenuated in platonin(200 μg/kg)-treated mice. In conclusion, platonin exhibited remarkable neuroprotective properties against MCAO-induced ischemia in a mouse model through its antiaggregation, antiinflammatory and antiradical properties. The observed therapeutic efficacy of platonin may consider being a novel medcine against ischemic stroke.",
author = "Sheu, {Joen Rong} and Chen, {Zhih Cherng} and Thanasekaran Jayakumar and Chou, {Duen Suey} and Yen, {Ting Lin} and Lee, {Hsing Ni} and Pan, {Szu Han} and Hsia, {Chih Hsuan} and Yang, {Chih Hao} and Hsieh, {Cheng Ying}",
year = "2017",
month = "2",
day = "6",
doi = "10.1038/srep42277",
language = "English",
volume = "7",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - A novel indication of platonin, a therapeutic immunomodulating medicine, on neuroprotection against ischemic stroke in mice

AU - Sheu, Joen Rong

AU - Chen, Zhih Cherng

AU - Jayakumar, Thanasekaran

AU - Chou, Duen Suey

AU - Yen, Ting Lin

AU - Lee, Hsing Ni

AU - Pan, Szu Han

AU - Hsia, Chih Hsuan

AU - Yang, Chih Hao

AU - Hsieh, Cheng Ying

PY - 2017/2/6

Y1 - 2017/2/6

N2 - Thrombosis and stroke are major causes of disability and death worldwide. However, the regular antithrombotic drugs may have unsatisfactory results and side effects. Platonin, a cyanine photosensitizing dye, has been used to treat trauma, ulcers and some acute inflammation. Here, we explored the neuroprotective effects of platonin against middle cerebral artery occlusion (MCAO)-induced ischemic stroke in mice. Platonin(200 μg/kg) substantially reduced cerebral infarct volume, brain edema, neuronal cell death and neurological deficit scores, and improved the MCAO-reduced locomotor activity and rotarod performance. Platonin(5-10 μM) potently inhibited platelet aggregation and c-Jun NH2-terminal kinase (JNK) phosphorylation in collagen-activated platelets. The antiaggregation effect did not affect bleeding time but increased occlusion time in platonin(100 and 200 μg/kg)-treated mice. Platonin(2-10 μM) was potent in diminishing collagen- and Fenton reaction-induced a OH formation. Platonin(5-10 μM) also suppressed the expression of nitric oxide, inducible nitric oxide synthase, cyclooxygenase-2, interleukin-1β, and JNK phosphorylation in lipopolysaccharide-stimulated macrophages. MCAO-induced expression of 3-nitrotyrosine and Iba1 was apparently attenuated in platonin(200 μg/kg)-treated mice. In conclusion, platonin exhibited remarkable neuroprotective properties against MCAO-induced ischemia in a mouse model through its antiaggregation, antiinflammatory and antiradical properties. The observed therapeutic efficacy of platonin may consider being a novel medcine against ischemic stroke.

AB - Thrombosis and stroke are major causes of disability and death worldwide. However, the regular antithrombotic drugs may have unsatisfactory results and side effects. Platonin, a cyanine photosensitizing dye, has been used to treat trauma, ulcers and some acute inflammation. Here, we explored the neuroprotective effects of platonin against middle cerebral artery occlusion (MCAO)-induced ischemic stroke in mice. Platonin(200 μg/kg) substantially reduced cerebral infarct volume, brain edema, neuronal cell death and neurological deficit scores, and improved the MCAO-reduced locomotor activity and rotarod performance. Platonin(5-10 μM) potently inhibited platelet aggregation and c-Jun NH2-terminal kinase (JNK) phosphorylation in collagen-activated platelets. The antiaggregation effect did not affect bleeding time but increased occlusion time in platonin(100 and 200 μg/kg)-treated mice. Platonin(2-10 μM) was potent in diminishing collagen- and Fenton reaction-induced a OH formation. Platonin(5-10 μM) also suppressed the expression of nitric oxide, inducible nitric oxide synthase, cyclooxygenase-2, interleukin-1β, and JNK phosphorylation in lipopolysaccharide-stimulated macrophages. MCAO-induced expression of 3-nitrotyrosine and Iba1 was apparently attenuated in platonin(200 μg/kg)-treated mice. In conclusion, platonin exhibited remarkable neuroprotective properties against MCAO-induced ischemia in a mouse model through its antiaggregation, antiinflammatory and antiradical properties. The observed therapeutic efficacy of platonin may consider being a novel medcine against ischemic stroke.

UR - http://www.scopus.com/inward/record.url?scp=85011838826&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011838826&partnerID=8YFLogxK

U2 - 10.1038/srep42277

DO - 10.1038/srep42277

M3 - Article

AN - SCOPUS:85011838826

VL - 7

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 42277

ER -